Health economist Elliot Fisher tells House committee Vermont must strengthen state oversight, expand primary care to rein in costs

Doctor Elliot Fisher, a health policy researcher, told the House Committee on Health Care that Vermont faces an affordability and access crisis driven by wide variation in practice, market concentration and insufficient primary care.

Fisher said the state has “a great opportunity” because the Green Mountain Care Board has broad authority to control provider prices, but it lacks sufficient resources and, in his view, possibly the independent capacity to implement the kinds of systemwide reforms he recommended.

Fisher summarized three long‑standing findings from his work with the Dartmouth Atlas of Health Care: that evidence to constrain clinical decisionmaking is often inadequate; that patients’ preferences vary; and that most geographic differences in spending are driven by how much care the system delivers rather than by patient need. “There are 10‑fold differences” in rates of some procedures across regions, he said, and much of the excess spending is driven by more hospital days and more specialist visits rather than more evidence‑based treatments.

Why it matters: Fisher said the consequences go beyond insurance premiums. Citing recent working‑paper research, he said a 1% increase in health‑care prices functions like a payroll tax and can reduce county income and increase unemployment; the paper also linked price increases to higher rates of suicide and overdose in some analyses. He noted primary care access has declined nationwide and estimated “about 100 million Americans” lack adequate local primary care, a problem he said is likely mirrored in Vermont.

Fisher urged the committee to require more rapid, practical planning and to prioritize universal access to primary care in any implementation work. “If you could do universal access for primary care, it would be my first, first next wish for what something this session would include in the bill,” he said. He recommended that the entity given planning authority return competing proposals for an all‑payer primary‑care approach and a short timetable for implementation.

Evidence and examples: Fisher pointed to organized, integrated systems—Kaiser Permanente, Intermountain Healthcare and a set of other systems including University Hospitals/Cleveland and Nuka in Alaska—as models that cut costs by investing in quality, standardizing clinical practice and reducing complications and unnecessary length of stay. He described Intermountain’s efforts to lower hip‑replacement costs and to shrink surgical length of stay from six days to roughly two, improvements he said lowered costs and preserved or improved net revenue.

Fisher warned of familiar obstacles: the “balloon problem,” by which reductions in one payment category can be shifted into others; concentrated hospital markets that act like monopolies; and a collective‑action problem in which organized special interests are more effective than diffuse public pressure. He repeated his recommendation for a single, accountable, transparent and independent oversight entity with the authority and resources to set total cost of care targets, measure performance and enforce or oversee payment reform.

Committee members asked Fisher about specifics: how to translate savings into lower commercial rates, how to strengthen care coordination in practice, and how to fund implementation. Fisher said regulators can influence price and payment design and that planning bodies should include measurable, rapid deliverables (for example, a one‑year plan for primary care expansion) rather than only long‑range reports.

Ending: Fisher concluded by urging the committee to use the current crisis—he cited recent large commercial‑rate increases and pressure on insurers and hospitals—as an opportunity to accelerate quality improvement and payment reforms that expand primary care and reduce avoidable hospital use.